| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. | CHIEF FINANCIAL OFFICER | Stock Option (Right to Buy) | 62.1K | Aug 2, 2024 | Direct | ||
| BIOCEPT INC | Director | Employee Stock Option (right to buy) | 10K | Jul 8, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ADVM | Adverum Biotechnologies, Inc. | Aug 2, 2024 | 1 | $0 | 4 | Aug 6, 2024 | CHIEF FINANCIAL OFFICER |
| ADVM | Adverum Biotechnologies, Inc. | Feb 12, 2024 | 1 | $0 | 4 | Feb 14, 2024 | CHIEF FINANCIAL OFFICER |
| ADVM | Adverum Biotechnologies, Inc. | Aug 3, 2023 | 1 | $0 | 4 | Sep 5, 2023 | Chief Financial Officer |
| ADVM | Adverum Biotechnologies, Inc. | Jun 7, 2023 | 1 | $145K | 4 | Jun 9, 2023 | Chief Financial Officer |
| ADVM | Adverum Biotechnologies, Inc. | Dec 12, 2022 | 0 | $0 | 3 | Dec 15, 2022 | Chief Financial Officer |
| BIOC | BIOCEPT INC | Jul 8, 2022 | 1 | $0 | 4 | Sep 8, 2022 | Director |
| ALEC | Alector, Inc. | Sep 8, 2021 | 0 | $0 | 3 | Sep 9, 2021 | Interim Chief Financial Ofcr |
| BIOC | BIOCEPT INC | Jul 16, 2021 | 1 | $0 | 4 | Jul 20, 2021 | Director |
| BIOC | BIOCEPT INC | Jul 16, 2021 | 0 | $0 | 3 | Jul 20, 2021 | Director |